Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ASCENDIS PHARMA A/S

(ASND)
  Report
Delayed Nasdaq  -  04:00 2022-10-03 pm EDT
99.42 USD   -3.72%
10/03Ascendis Pharma A/s : INCORPORATION BY REFERENCE - Form 6-K
PU
10/03European ADRs Surge Higher in Monday Trading
MT
10/03Ascendis Pharma Announces Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101, a Phase 1/2 Clinical Trial of TransCon™ TLR7/8 Agonist in Solid Tumors
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Thursday Trading

08/11/2022 | 11:10am EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AMARIN CORPORATION PLC 2.75% 1.12 Delayed Quote.-66.77%
ASCENDIS PHARMA A/S -3.72% 99.42 Delayed Quote.-23.24%
ASTRAZENECA PLC -1.39% 9806 Delayed Quote.13.00%
CARNIVAL CORPORATION -2.56% 6.85 Delayed Quote.-65.06%
CELLECTIS S.A. -4.53% 2.318 Real-time Quote.-68.84%
DIAGEO PLC -2.37% 3707.5 Delayed Quote.-8.14%
ERYTECH PHARMA S.A. 3.48% 0.58 Real-time Quote.-72.64%
GENFIT 1.89% 3.872 Real-time Quote.-10.29%
GSK PLC 1.06% 1319.6 Delayed Quote.-19.71%
LONDON BRENT OIL 0.70% 89.36 Delayed Quote.9.50%
MEREO BIOPHARMA GROUP PLC 3.37% 0.8901 Delayed Quote.-44.37%
SANOFI 1.79% 79.8 Real-time Quote.-9.91%
SEQUANS COMMUNICATIONS S.A. -2.52% 3.48 Delayed Quote.-24.68%
SHELL PLC 2.36% 2299.5 Delayed Quote.41.79%
VEON LTD. 3.16% 0.3301 Delayed Quote.-80.70%
VERONA PHARMA PLC -1.08% 10.11 Delayed Quote.50.45%
WTI 0.79% 83.988 Delayed Quote.8.90%
ZEALAND PHARMA A/S -3.62% 167.5 Delayed Quote.19.78%
All news about ASCENDIS PHARMA A/S
10/03Ascendis Pharma A/s : INCORPORATION BY REFERENCE - Form 6-K
PU
10/03European ADRs Surge Higher in Monday Trading
MT
10/03Ascendis Pharma Announces Recommended Phase 2 Dose and Cohort Expansion for transcendIT..
AQ
09/30Ascendis Pharma A/s : Articles of Association - Form 6-K
PU
09/29Ascendis Pharma Added to Wedbush Best Ideas List
MT
09/22European ADRs Move Lower in Thursday Trading
MT
09/22Wells Fargo Adjusts Ascendis Pharma Price Target to $172 From $167, Maintains Overweigh..
MT
09/14Ascendis Pharma A/s : Articles of Association - Form 6-K
PU
09/13Transcript : Ascendis Pharma A/S Presents at Morgan Stanley 20th Annual Globa..
CI
09/12Ascendis Pharma A/S Appoints William Carl Fairey Jr. and Siham Imani as Class I Directo..
CI
More news
Analyst Recommendations on ASCENDIS PHARMA A/S
More recommendations
Financials
Sales 2022 34,8 M 34,2 M 34,2 M
Net income 2022 -500 M -492 M -492 M
Net cash 2022 620 M 610 M 610 M
P/E ratio 2022 -11,2x
Yield 2022 -
Capitalization 5 645 M 5 553 M 5 553 M
EV / Sales 2022 144x
EV / Sales 2023 39,1x
Nbr of Employees 639
Free-Float 10,3%
Chart ASCENDIS PHARMA A/S
Duration : Period :
Ascendis Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASCENDIS PHARMA A/S
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 14
Last Close Price 101,06 €
Average target price 146,14 €
Spread / Average Target 44,6%
EPS Revisions
Managers and Directors
Jan M°ller Mikkelsen President, CEO & Executive Director
Scott Thomas Smith Chief Financial Officer & Senior Vice President
Albert Cha Chairman
Birgitte Volck SVP, Head-Clinical Development & Medical Affairs
Kennett Sprog°e Senior Vice President, Head-Innovation & Research
Sector and Competitors
1st jan.Capi. (M$)
ASCENDIS PHARMA A/S-23.24%5 553
GILEAD SCIENCES, INC.-14.17%77 320
VERTEX PHARMACEUTICALS35.44%74 255
REGENERON PHARMACEUTICALS, INC.16.41%73 646
BIONTECH SE-47.68%32 778
WUXI APPTEC CO., LTD.-39.54%29 044